Pharmaniaga Berhad (KLSE:PHARMA)

Market Cap	1.64B +364.2%
Revenue (ttm)	4.05B +5.2%
Net Income	50.40M -62.9%
EPS	0.01 -89.1%
Shares Out	6.56B
PE Ratio	24.31
Forward PE	15.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,129,100
Average Volume	8,909,585
Open	0.2500
Previous Close	0.2400
Day's Range	0.2450 - 0.2550
52-Week Range	0.1300 - 0.3400
Beta	n/a
RSI	40.13
Earnings Date	May 15, 2026

About Pharmaniaga Berhad

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines; supply and installation of medical and hospital equipment; and research and development of pharmaceutical products. The company also produces and dis...

• Founded: 1994
• Employees: 3,502
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: PHARMA

Financial Performance

In 2025, Pharmaniaga Berhad's revenue was 3.93 billion, an increase of 4.48% compared to the previous year's 3.76 billion. Earnings were 48.51 million, a decrease of -63.20%.